avapritinib updates in advanced systemic mastocytosis: explorer and pioneer
Published 4 years ago • 676 plays • Length 2:21Download video MP4
Download video MP3
Similar videos
-
1:46
updated analyses from the pathfinder trial: avapritinib therapy in advanced systemic mastocytosis
-
2:03
the safety and efficacy of avapritinib in patients with advanced systemic mastocytosis
-
3:10
pioneer trial update: avapritinib for indolent systemic mastocytosis
-
3:05
explorer: avapritinib in systemic mastocytosis
-
1:10
avapritinib for advanced systemic mastocytosis: analysis of patient-reported outcomes from explorer
-
2:56
insights into the treatment and management of advanced systemic mastocytosis
-
1:51
responses to avapritinib in patients with advanced systemic mastocytosis
-
2:20
avapritinib fda approval for advanced systemic mastocytosis
-
41:14
from discovery to functional assays therapeutic antibody research by miltenyi biotec
-
1:50
unmet needs and challenges in mastocytosis
-
23:07
bis monitoring
-
1:00
complete remission seen in advanced systemic mastocytosis with avaritinib
-
5:21
systemic mastocytosis: current treatments and emerging targeted agents
-
9:29
pioneer: avapritinib in patients with indolent systemic mastocytosis
-
2:37
current approaches to treating systemic mastocytosis
-
5:14
avapritinib for indolent systemic mastocytosis in the pioneer trial
-
2:15
mars: mutation-adjusted risk score for advanced systemic mastocytosis
-
4:46
management strategies for advanced systemic mastocytosis
-
2:07
avapritinib for indolent systemic mastocytosis
-
1:46
unmet needs and challenges in advanced systemic mastocytosis
-
1:44
emerging novel agents for the treatment of mastocytosis
-
1:28
developments in the mastocytosis field at ash 2020